Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Learning Impairments Among Survivors of Childhood Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				6 to 18				NCI, Other				MEMFX2 RO1-CA078957, UO1-CA81445, P30-CA2Z1765, NCT00576472


2.		Methylphenidate Treatment of Cancer-Related Fatigue

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Active				18 to 60				Other				6520-9959-02 NCT00758407


3.		Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 to 75				Other				DCIC 03 29 NCT00273741


4.		Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Other				2003-0925 NCT00418691


5.		Methylphenidate Study in Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Supportive care, Treatment				Active				18 and over				Other				ID00-372 NCT00516269


6.		Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 to 85				Other				LEUPR_L_01 07-0350-C, NCT00593853


7.		Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				IIR 03-194 01153, 10-0603, CPC-04115-LX, NCT00129467


8.		Methylphenidate and a Nursing Telephone Intervention for Fatigue

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Educational/Counseling/Training, Supportive care				Active				18 and over				Other				2005-0613 NCT00424099

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute